This test is designed for detection of antibodies to SARS-CoV-2 in plasma from individuals suspected to be recovering, or recovered, from COVID-19 by their healthcare provider. It can be used to:
· Identify potential convalescent plasma donors
· Support diagnosis of acute COVID-19 illness in persons who present late. For persons who present 9–14 days after illness onset, serologic testing can be offered in addition to the recommended viral direct detection methods
· Support a diagnosis when patients present with late complications of COVID-19 illness, such as multisystem inflammatory syndrome in children
· Support epidemiologic studies and for surveillance purposes, such as understanding the transmission dynamics of the virus in the general population